ID   LNCaP C4-2Pr
AC   CVCL_6E93
SY   C4-2Pr; C4-2 Pr; C4-2 Primary tumor
DR   Wikidata; Q54902821
RX   PubMed=8168083;
CC   Sequence variation: Homozygous for AR p.Thr878Ala (c.2632A>G) (from parent cell line).
CC   Sequence variation: Heterozygous for MEN1 p.Tyr313Ter (c.939T>A) (from parent cell line).
CC   Sequence variation: Heterozygous for PIK3R1 p.Arg639Ter (c.1915C>T) (from parent cell line).
CC   Derived from metastatic site: Left supraclavicular lymph node.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_4782 ! LNCaP C4-2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 06-09-19; Version: 5
//
RX   PubMed=8168083;
RA   Thalmann G.N., Anezinis P.E., Chang S.-M., Zhau H.E., Kim E.E.,
RA   Hopwood V.L., Pathak S., von Eschenbach A.C., Chung L.W.K.;
RT   "Androgen-independent cancer progression and bone metastasis in the
RT   LNCaP model of human prostate cancer.";
RL   Cancer Res. 54:2577-2581(1994).
//